Suchergebnisse - "145155-23-3"

PubPharm (127)

1

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

2

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir : A Phase 2 Open-label Randomized Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Tam, A. | Zhang, R. | Lung, K. | +23

3

A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis

enthalten in: The International journal of neuroscience | 2022

von Najafi, S. | Moghadam, N. | Saadat, P. | +6

4

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19 : a randomised clinical trial

enthalten in: Annals of medicine | 2021

von Li, C. | Luo, F. | Liu, C. | +24

5

Role of interferon therapy in severe COVID-19 : the COVIFERON randomized controlled trial

enthalten in: Scientific reports | 2021

von Alavi Darazam, I. | Shokouhi, S. | Pourhoseingholi, M. | +19

6

Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Khamis, F. | Al Naabi, H. | Al Lawati, A. | +8

7

Interferon β-1b in treatment of severe COVID-19 : A randomized clinical trial

enthalten in: International immunopharmacology | 2020

von Rahmani, H. | Davoudi-Monfared, E. | Nourian, A. | +6

8

Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome

enthalten in: The New England journal of medicine | 2020

von Arabi, Y. | Asiri, A. | Assiri, A. | +49

9

Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients

enthalten in: Brain and behavior | 2020

von Hänninen, K. | Jääskeläinen, O. | Herukka, S. | +1

10

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2020

von Hung, I. | Lung, K. | Tso, E. | +41

CommentIn: Lancet. 2020 May 30;395(10238):1670-1671. - PMID 32401712

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]